Indiana’s chief judge to serve on opioid panel
The panel will help promote collaboration among treatment providers, criminal justice systems and child welfare agencies.
Pharmaceutical
Articles
Animal-health biz Elanco under the weather; Lilly won’t rule out spinoff
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
Lilly eliminating 3,500 jobs as part of cost-cutting plan
Indianapolis-based pharmaceutical giant Eli Lilly and Co. said the 3,500 jobs represent 8.3 percent of its global workforce. Lilly hopes the cuts will save it $500 million a year.
Lilly competitor reaches $46.5M settlement with U.S. over safety info
Danish drugmaker Novo Nordisk says it has reached a settlement over allegations that it hadn’t properly communicated safety information when marketing a medicine to treat type 2 diabetes.
Lilly shares rise on surprising news from FDA on arthritis drug
The Indianapolis drugmaker said it will not be required to conduct another expensive, time-consuming clinical trial for the potential blockbuster.
Lilly insulin prices come under microscope
Over the past 20 years, while the price of a gallon of milk climbed 23 percent and the sticker on a Dodge Caravan minivan rose 21 percent, the list price of the insulin Humalog shot up 1,157 percent.
Trump lashes out after Merck exec resigns from president’s council
President Donald Trump criticized drug prices immediately after Merck & Co.’s CEO quit the president’s council of manufacturing executives Monday, to take a “stand against intolerance and extremism.”
Lilly, other drug giants hunt for patients in India’s remote corners
Global pharmaceutical companies including Indianapolis-based Eli Lilly and Co. are heading into smaller cities and rural areas to learn about the health care needs of about 70 percent of India’s population.
Lilly to pay up to $400M to buy rights for early-stage immune drug
The deal is Eli Lilly and Co.’s latest push into a growing disease area for such disorders as arthritis, lupus and multiple sclerosis.
Drugmakers aren’t sweating next wave of patent losses
Drugmakers like Eli Lilly and Co. plunged off a patent cliff earlier this decade, losing billions in sales as lucrative branded drugs lost exclusivity. An expensive lobbying effort aimed at preventing a repeat is paying off.
British Supreme Court rules in Eli Lilly’s favor in drug dispute
Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drugmaker Actavis over Lilly's Alimta cancer treatment.
Indiana adding opioid treatment programs at five sites
The new sites are located at health centers in Johnson, Allen, Vigo, Monroe and Tippecanoe counties, the Indiana Family and Social Services Administration announced Wednesday morning.
Pharmakon collected $560K in incentives before ceasing operations
Noblesville-based Pharmakon had a history of making state and local incentive agreements before suspending operations last year after a Food and Drug Administration investigation uncovered safety issues and possible criminal activity.
Pharmacy boss blamed for meningitis outbreak gets 9 years
The co-owner of a pharmacy responsible for the deaths of 76 people was sentenced Monday to nine years in prison. Indiana was one of the state hit hardest by the 2012 nationwide fungal meningitis outbreak.
Performance gap widening in some generic drugs, researchers say
As medicines—especially those that treat conditions such as anxiety or depression—are becoming more complex, it’s not just the mix of active ingredients that generic drugmakers have to replicate. It’s also the release mechanism.
Indiana crackdown on opioids sparks more pharmacy robberies
While making opioid prescriptions harder to get, Indiana’s crackdown helped spur a twofold increase in robberies of pharmacies that exacerbated the state’s standing as No. 1 in the nation for those crimes.
Lilly, Pfizer get boost for non-opioid pain drug
The companies say the drug, now in late-stage clinical trials, could be more effective for pain treatment than opioids—a dangerous category of pain killers that includes hydrocodone, morphine and fentanyl—without the abuse potential of such medications.
Pharmakon owner, compliance director face criminal charges
The owner and the director of compliance for Noblesville-based Pharmakon Pharmaceuticals Inc. have been charged with multiple criminal counts related to the sale of over-potent compounded painkillers that sickened at least three infants.
Nevada forces drugmakers to reveal insulin pricing, profits
America's three insulin manufacturers—Indianapolis-based Eli Lilly and Co., Sanofi and Novo Nordisk—would face fines of $5,000 daily if they fail to provide the data.
Drugmaker cashing in on opioid epidemic, one state law at a time
In statehouses across the country and in Congress, drugmaker Alkermes is pushing its own addiction treatment while contributing to misconceptions and stigma about other medications used to treat opioid addiction.